# Hematology Consultation

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Marie Curie (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ET013-SYN
- Date: 2026-05-18
- Fictional facility: St. Posthumous Health Center
- Fictional author: Lukas Brenner, MD
- Calendar frame: modern shifted

- Requested by: Adaeze Nwosu, MD

## Reason for consultation

Pancytopenia with a low reticulocyte count in a 66-year-old physicist with decades of occupational radiation exposure, suspicious for marrow failure. Please assess urgently, with bone marrow aspirate and biopsy, cytogenetics, and PNH testing, and advise on treatment. **S**

## History

Madame Curie is seen at the request of Dr. Nwosu one week after a blood count showed pancytopenia with a low reticulocyte count. She is less breathless since the transfusion but still tires by midafternoon. New bruises appear on her arms and shins without injury; she has had no nosebleeds, gum bleeding, blood in the urine or stool, or further fever. Glare in the right eye is slowing her reading. She has worked for decades with radium sources and X-ray equipment and has stopped laboratory work since the last visit. She takes no medicines and wants the full data and plan. **S**

## Examination

| System | Finding |
|---|---|
| General | Pale, alert, precise, and composed |
| Skin | Scattered bruises on the forearms and shins; a few petechiae on the lower legs; thin, scarred fingertip skin |
| Mouth | No gum bleeding or blood blisters; no ulcers |
| Lymph nodes | No lymphadenopathy |
| Abdomen | No hepatomegaly or splenomegaly |
| Heart | Regular rhythm, pulse 92; soft flow murmur |

BP 116/70 mmHg; pulse 92 bpm; respirations 16/min; temperature 36.9 °C; oxygen saturation 98% on room air; weight 51 kg; BMI 20.7 kg/m². All vital signs are synthetic.

## Data reviewed

The blood count, reticulocyte count, and nutritional, hemolysis, and kidney studies from one week ago; today's blood count and reticulocyte count; and today's bone marrow aspirate and trephine biopsy with cytogenetics and PNH flow cytometry. No liver enzymes or viral serology are on record. Hemoglobin: 8.9 g/dL (low); White blood cell count: 1.8 10*3/uL (low); Absolute neutrophil count: 0.4 10*3/uL (low); Platelet count: 15 10*3/uL (low); MCV: 101 fL (high); Absolute reticulocyte count: 12 10*3/uL (low). All results are synthetic.

## Assessment

1. **Severe aplastic anemia, newly confirmed** (D61.2). Marrow cellularity about 10 percent with no dysplasia, fibrosis, or malignant cells; normal cytogenetics exclude hypoplastic myelodysplasia, and there is no PNH clone. Normal B12, folate, LDH, and bilirubin and no organomegaly or lymphadenopathy point away from other causes. Neutrophils 0.4, platelets 15, and reticulocytes 12 thousand per microliter meet the criteria for severe, not very severe, aplastic anemia; hemoglobin is 8.9 g/dL after the transfusion. An immune mechanism cannot be excluded, so standard immunosuppression is chosen; transplant is not chosen at 66. **S**
2. **Checks before immunosuppression**. Creatinine 0.78 mg/dL and potassium 4.1 from one week ago allow cyclosporine. No ALT and no hepatitis B, hepatitis C, HIV, CMV, or EBV serology are on record before treatment; bilirubin was 0.6 mg/dL a week ago. With neutrophils 0.4 and platelets 15, treatment starts today and these tests are to follow with the next blood draw. **S**
3. **Occupational exposure to ionizing radiation** (Z57.1). Decades of exposure, recorded in her history. The link to her marrow failure is probable but not proven, so immunosuppression is still offered in case an immune mechanism contributes. **S**
4. **Chronic radiodermatitis of the fingertips** (L58.1). Stable thin, scarred skin without ulceration; vulnerable to injury while platelets are low. **S**

## Recommendations

1. Horse antithymocyte globulin as a four-day infusion course in the hematology unit, starting today.
2. Cyclosporine (modified) 100 mg twice daily from today, with the dose adjusted by hematology to trough levels; first trough within the first weeks.
3. Eltrombopag 150 mg once daily from today, on an empty stomach two hours before or four hours after food, dairy, or antacids.
4. Acyclovir 400 mg twice daily as antiviral prophylaxis throughout immunosuppression; Pneumocystis prophylaxis is not needed with this regimen.
5. Send ALT and hepatitis B, hepatitis C, HIV, CMV, and EBV serology with the next blood draw.
6. Weekly blood count with differential and reticulocytes through the hematology day unit for the first months; creatinine, potassium, and ALT every two weeks; blood pressure and weight at every visit.
7. Irradiated, leukocyte-depleted blood products from now on (blood bank flag placed). Red cells for symptoms or hemoglobin below 7 to 8 g/dL; platelet support per the hematology unit protocol during the antithymocyte globulin course, and for bleeding afterward.
8. No antibacterial or antifungal prophylaxis for now; review under local policy if neutrophils stay at or below 0.5. Same-day assessment for a temperature of 38 °C or higher, bleeding precautions, and no aspirin or NSAIDs; written plan given.
9. Inactivated vaccines only; no live vaccines.
10. No further occupational radiation exposure while counts recover, and an occupational health review of shielding and dosimetry for her laboratory staff.
11. Emollient and protection from injury for the fingertips while platelets are low.
12. Formal response assessment at three and six months; counts are not expected to rise in the first weeks.

## Strengths and supports

- Supports: two adult daughters, one also a scientist, and a sister who is a physician **S**

## Communication

Discussed with Dr. Nwosu by telephone today. The marrow results, the severity criteria, and the treatment plan were reviewed in detail with the patient, who agreed to start treatment today. **S**

## Follow-up

Hematology unit this week for the antithymocyte globulin course, then weekly blood counts through the hematology day unit, with hematology managing the cyclosporine dose. Primary care review in three weeks with blood counts, kidney function, potassium, and ALT, and a review of the right-eye glare. **S**

## Guideline basis

- Guidelines for the diagnosis and management of adult aplastic anaemia: A British Society for Haematology Guideline (2024), British Society for Haematology (British Journal of Haematology)
- CMID: Clinical Monitoring Intelligence Database, anemia and cataract monographs (2026), Aether Forge
